257 results on '"Schroers, Roland"'
Search Results
2. High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factors
3. Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway
4. High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system
5. Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis
6. Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial
7. Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
8. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma
9. Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis
10. Liquid biopsy based HER2 amplification status in gastric cancer patients indicates clinical response
11. Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
12. Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors
13. GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany
14. Optical Genome Mapping in MDS and AML as tool for structural variant profiling—comment and data update on Yang et al.: “High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance”
15. Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome.
16. Comparison of peripheral blood automated hematopoietic progenitor cell count and flow cytometric CD34+ cell count.
17. Management of Patients Undergoing CAR-T Cell Therapy in Germany.
18. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
19. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry
20. Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells
21. Monocytes-neutrophils-ratio as predictive marker for failure of first induction therapy in AML
22. Acute myeloid leukemia with central diabetes insipidus
23. Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
24. Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
25. Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma.
26. Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients.
27. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS
28. Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study
29. HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis
30. Novel NUP98::ASH1L Gene Fusion in Acute Myeloid Leukemia Detected by Optical Genome Mapping.
31. Liquid biopsy can cure early colorectal cancer recurrence – Case Report.
32. Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM
33. Bone Marrow Immune Signatures in Multiple Myeloma Are Linked to Tumor Heterogeneity and Treatment Outcome
34. Optical Genome Mapping for Cytogenetic Diagnostics in AML.
35. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
36. Outcome and prognostic factors of very old patients with primary CNS lymphoma: a retrospective analysis of patients ≥80 years treated with high-dose methotrexate-based chemotherapy.
37. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients - data files
38. Anti-CD19 CAR T cells for refractory myasthenia gravis
39. Real World Results of Brexucabtagene Autoleucel for Patients with Relapsed/Refractory Mantle Cell Lymphoma - First German/Swiss Analysis
40. Successful chimeric antigen receptor (CAR) T-cell treatment in aggressive lymphoma despite coronavirus disease 2019 (CoVID-19) and prolonged severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) replication
41. Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report
42. Patients with primary central nervous system lymphoma not eligible for clinical trials
43. Case Report: Hemophagocytic Lymphohistiocytosis and Non-Tuberculous Mycobacteriosis Caused by a Novel GATA2 Variant
44. Case Report: Hemophagocytic lymphohistiocytosis and non-tuberculous mycobacteriosis caused by a novel \(\it GATA2\) variant
45. Computertomography-Based Prediction of Complete Response Following Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
46. Analysis of U2 Small Nuclear RNA Fragments in the Bile Differentiates Cholangiocarcinoma from Primary Sclerosing Cholangitis and Other Benign Biliary Disorders
47. Pelger-Huët anomaly and T-cell lymphoma
48. Outcomes of anti‐programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real‐world analysis.
49. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
50. High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.